Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nandini Sharrel Menon
Observed names:
N.S. Menon,
Nandini Menon
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
Observed institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
ORCID:
0000-0002-4214-5799
Observed ORCID:
0000-0002-4214-5799
OpenAlex ID:
A5104326322
Results of phase 3 randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer unsuitable for cisplatin-based chemoradiation.
2022
·
Vijay Maruti Patil
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
12
Phase III randomized study comparing ultra-low dose immunotherapy to standard cytotoxic chemotherapy for solid tumors in second line and beyond setting (DELII: Development of Low dose Immunotherapy in India).
2025
·
Vanita Noronha
, Nandini Sharrel Menon
, et al.
·
Journal of Clinical Oncology
·
7
PDF
Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer.
2022
·
Vijay Maruti Patil
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
6
Optimal cumulative cisplatin dose for radio-sensitization in locally advanced head and neck cancer.
2020
·
Atanu Bhattacharjee
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
6
Ultra-low-dose immunotherapy plus oral metronomic chemotherapy versus paclitaxel-carboplatin in platinum-sensitive recurrent or metastatic head and neck squamous cell carcinoma: A randomized phase III trial.
2026
·
Minit Jalan Shah
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
5
PDF
Anaplastic Cancer: Our Experience
2022
·
Aditya Pavan Kumar Kanteti
, Joy Ghose
, et al.
·
Indian Journal of Surgical Oncology
·
5
A retrospective analysis of patients administered neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin with oral metronomic chemotherapy (OMCT) in locally advanced borderline resectable/technically unresectable head and neck cancers.
2022
·
Shruti Pathak
, Zoya Peelay
, et al.
·
Journal of Clinical Oncology
·
4
Wait or treat? managing asymptomatic brain metastases in oncogene-mutated NSCLC: Results of a phase-III randomized controlled trial.
2026
·
Anil Ramakant Tibdewal
, Jai Prakash Agarwal
, et al.
·
Journal of Clinical Oncology
·
3
Real-world analysis of use of lenvatinib in differentiated thyroid cancers.
2022
·
Zoya Peelay
, Shruti Pathak
, et al.
·
Journal of Clinical Oncology
·
3
Six-year follow-up from the weekly-three-weekly study comparing cisplatin once-a-week to once-every-three-weeks as concurrent chemoradiation for locally advanced head and neck squamous cell carcinoma.
2022
·
Vanita Noronha
, Vijay Maruti Patil
, et al.
·
Journal of Clinical Oncology
·
3
Metronomic adjuvant chemotherapy (MACE) in locally advanced oral cavity squamous cell carcinoma post-surgery and adjuvant treatment (MACE postop): A phase III randomized controlled trial.
2026
·
Pankaj Chaturvedi
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
2
PDF
The use of docetaxel as a radiosensitizer in patients with head and neck cancer unsuitable for cisplatin based chemoradiation: Landmark 3-year survival analysis of a randomized phase III trial (DHANUSH).
2025
·
Sneha Dhar
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
2
PDF
719P Genomic profiling of driver gene alterations in patients with non-small cell lung cancer, patterns of treatment and impact on survival outcomes: A single center experience of more than 1200 patients
2024
·
M.J. Shah
, V. Noronha
, et al.
·
Annals of Oncology
·
2
PDF
Neoadjuvant chemotherapy followed by definitive chemoradiation in technically unresectable oral cavity squamous cancers.
2023
·
Mehak Trikha
, Vijay Maruti Patil
, et al.
·
Journal of Clinical Oncology
·
2
Low-cost oral metronomic versus intravenous chemotherapy in recurrent, inoperable and metastatic head and neck cancer: Phase III Metro-CIS study.
2020
·
Nandini Sharrel Menon
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
2
A phase 3 randomized trial comparing temozolomide with PCV as adjuvant chemotherapy in grade 2 and 3 diffuse gliomas in adults.
2026
·
Nandini Sharrel Menon
, Minit Jalan Shah
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Four-year landmark survival analysis of low-dose nivolumab added to metronomic chemotherapy in advanced head and neck squamous cell carcinoma: A phase III randomized trial.
2026
·
Mehak Trikha
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
·
1
Efficacy and safety of taxane platinum doublet chemotherapy with triple oral metronomic chemotherapy and low dose nivolumab as neoadjuvant therapy in locally advanced head and neck squamous cell carcinoma.
2025
·
Shriraj Shailesh Talati
, Minit Jalan Shah
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Metronomic systemic PCm (paclitaxel, carboplatin + metronomic) neoadjuvant chemotherapy in head and neck cancer.
2022
·
Gunjesh Kumar Singh
, Kumar Prabhash
, et al.
·
Journal of Clinical Oncology
·
1
865MO RMAC study: A randomized study evaluating the efficacy of metronomic adjuvant chemotherapy in patients with recurrent head and neck cancers post salvage surgery, not eligible for re-irradiation
2021
·
N.S. Menon
, V.M. Patil
, et al.
·
Annals of Oncology
·
1
Indication of adjuvant chemoradiation post neoadjuvant chemotherapy in very locally advanced borderline resectable head and neck cancer.
2020
·
Sudeep Das
, Vijay Maruti Patil
, et al.
·
Journal of Clinical Oncology
·
1
Prognostic value of radiological extranodal extension detected by computed tomography for predicting outcomes in head and neck squamous cell cancer patients treated with radical chemoradiotherapy.
2020
·
Abhishek Mahajan
, Ankur Chand
, et al.
·
Journal of Clinical Oncology
·
1
Low-dose pembrolizumab with chemotherapy in advanced NSCLC: A phase 3 randomized trial.
2026
·
Nandini Sharrel Menon
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
Gabapentin plus tramadol versus tramadol alone for chemoradiotherapy-induced oral mucositis pain in head and neck cancer: Results of a randomized phase III trial.
2026
·
Minit Jalan Shah
, Nandini Sharrel Menon
, et al.
·
Journal of Clinical Oncology
PDF
Is more always better?: Outcomes of TIP versus platinum doublet neoadjuvant chemotherapy in high-risk penile cancer.
2026
·
Shriraj Shailesh Talati
, Aditya Dhanawat
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
48
Citation count:
71
H-index:
5
I10-index:
1
Year
Topic
Type